Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
112
157.4
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SAR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Jamjoom Pharmaceuticals Factory Company SJSC
Other Current Liabilities
Jamjoom Pharmaceuticals Factory Company SJSC
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
|
Other Current Liabilities
ď·Ľ25.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
|
Other Current Liabilities
ď·Ľ422.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
2%
|
CAGR 10-Years
10%
|
|
|
M
|
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
|
Other Current Liabilities
ď·Ľ11.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Jamjoom Pharmaceuticals Factory Company SJSC
Glance View
Jamjoom Pharmaceuticals Factory Company SJSC, nestled in the heart of Saudi Arabia, has emerged as a formidable player in the Middle East's pharmaceutical landscape. Founded in 1994, the company was borne out of a vision to cater to the growing healthcare demands of the region, leveraging both high-tech manufacturing and rigorous scientific research. Initially focused on generic medications, Jamjoom Pharmaceuticals has since expanded its portfolio to include a diverse range of products from ophthalmology to dermatology. With a state-of-the-art manufacturing facility in Jeddah, it integrates advanced technologies into its processes, ensuring that its products meet global quality standards. The company's adherence to Good Manufacturing Practices (GMP) and its drive to innovate are reflected in its collaborations with international partners for research and development, exemplifying its commitment to producing affordable, high-quality medications. At the core of Jamjoom Pharmaceuticals' business model is a robust distribution network that spans across the Middle East and North Africa (MENA) region, facilitating seamless supply chain operations. Revenue is generated primarily through the sale of its diversified product line, which includes prescription medications, over-the-counter solutions, and specialized healthcare products. The company leverages relationships with hospitals, healthcare providers, and retail pharmacies to enhance its market penetration. Its strategic focus on emerging therapeutic areas and persistent efforts to expand its international presence are paying dividends as it grows its footprint beyond the MENA region. By consistently reinvesting in research and development, Jamjoom Pharmaceuticals keeps its pipeline replenished with innovations that not only promise to enhance patient outcomes but also ensure sustainable profitability in a competitive pharmaceutical market.
See Also
What is Jamjoom Pharmaceuticals Factory Company SJSC's Other Current Liabilities?
Other Current Liabilities
25.5m
SAR
Based on the financial report for Dec 31, 2023, Jamjoom Pharmaceuticals Factory Company SJSC's Other Current Liabilities amounts to 25.5m SAR.
What is Jamjoom Pharmaceuticals Factory Company SJSC's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 3Y
7%
Over the last year, the Other Current Liabilities growth was 44%. The average annual Other Current Liabilities growth rates for Jamjoom Pharmaceuticals Factory Company SJSC have been 7% over the past three years .
You don't have any saved screeners yet
